108 related articles for article (PubMed ID: 8580053)
1. Radiation therapy: are we getting value for money?
Barton MB; Gebski V; Manderson C; Langlands AO
Clin Oncol (R Coll Radiol); 1995; 7(5):287-92. PubMed ID: 8580053
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy: a long term cost benefit analysis in a North American region.
Glazebrook GA
Clin Oncol (R Coll Radiol); 1992 Sep; 4(5):302-5. PubMed ID: 1390347
[TBL] [Abstract][Full Text] [Related]
3. Audit in radiation therapy: long-term survival and cost of treatment.
Stevens G; Firth I
Australas Radiol; 1997 Feb; 41(1):29-34. PubMed ID: 9125063
[TBL] [Abstract][Full Text] [Related]
4. Cost-minimization analysis: radiation treatment with and without a multi-leaf collimator.
Foroudi F; Lapsley H; Manderson C; Yeghiaian-Alvandi R
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1443-8. PubMed ID: 10889400
[TBL] [Abstract][Full Text] [Related]
5. Estimating the benefit and cost of radiotherapy for lung cancer.
Barbera L; Walker H; Foroudi F; Tyldesley S; Mackillop W
Int J Technol Assess Health Care; 2004; 20(4):545-51. PubMed ID: 15609808
[TBL] [Abstract][Full Text] [Related]
6. Estimating the cost of radiotherapy for 5-year local control and overall survival benefit.
Batumalai V; Wong K; Shafiq J; Hanna TP; Gabriel G; Heberle J; Koprivic I; Kaadan N; King O; Tran T; Cassapi L; Forstner D; Delaney GP; Barton M
Radiother Oncol; 2019 Jul; 136():154-160. PubMed ID: 31015119
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
8. Assessing the cost-effectiveness of postmastectomy radiation therapy.
Marks LB; Hardenbergh PH; Winer ET; Prosnitz LR
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):91-8. PubMed ID: 10219800
[TBL] [Abstract][Full Text] [Related]
9. Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Beinart SC; Kolm P; Veledar E; Zhang Z; Mahoney EM; Bouin O; Gabriel S; Jackson J; Chen R; Caro J; Steinhubl S; Topol E; Weintraub WS
J Am Coll Cardiol; 2005 Sep; 46(5):761-9. PubMed ID: 16139122
[TBL] [Abstract][Full Text] [Related]
10. Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients.
Lee JH; Glick HA; Hayman JA; Solin LJ
J Clin Oncol; 2002 Jun; 20(11):2713-25. PubMed ID: 12039934
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of adding folinic acid to fluorouracil plus levamisole as adjuvant chemotherapy in patients with colon cancer in Germany.
Monz BU; König HH; Leidl R; Staib L; Link KH
Pharmacoeconomics; 2003; 21(10):709-19. PubMed ID: 12828493
[TBL] [Abstract][Full Text] [Related]
12. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation.
Weintraub WS; Mahoney EM; Lamy A; Culler S; Yuan Y; Caro J; Gabriel S; Yusuf S;
J Am Coll Cardiol; 2005 Mar; 45(6):838-45. PubMed ID: 15766816
[TBL] [Abstract][Full Text] [Related]
13. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
14. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of ramipril in patients at high risk for cardiovascular events : economic evaluation of the HOPE (Heart Outcomes Prevention Evaluation) study for Germany from the Statutory Health Insurance perspective.
Schädlich PK; Brecht JG; Rangoonwala B; Huppertz E
Pharmacoeconomics; 2004; 22(15):955-73. PubMed ID: 15449961
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.
Zhang Z; Mahoney EM; Kolm P; Spertus J; Caro J; Willke R; Weintraub WS
Am J Cardiovasc Drugs; 2010; 10(1):55-63. PubMed ID: 20104935
[TBL] [Abstract][Full Text] [Related]
17. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
18. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
